TYR and melanoma: Several studies (Curry et al, 1998; Farthman et al, 1998; Ghossein et al, 1998; Alao et al, 1999; Reinhold et al, 2001) have suggested a potential clinical use of the RT–PCR analysis of tyrosinase mRNA to detect circulating neoplastic cells in the peripheral blood of melanoma patients.